Cardiff Oncology Inc. (CRDF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cardiff Oncology Inc.

    NASDAQ: CRDF · Real-Time Price · USD
    2.05
    -0.03 (-1.44%)
    At close: Sep 12, 2025, 3:59 PM
    2.05
    0.00%
    After-hours: Sep 12, 2025, 04:10 PM EDT

    Cardiff Oncology Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 683K 488K 386K 359K
    Cost of Revenue
    		 n/a 398K 200K 500K
    Gross Profit
    		 683K 488K 186K -141K
    Operating Income
    		 -48.65M -45.41M -39.9M -28.86M
    Interest Income
    		 3.26M 4.07M 1.58M 264K
    Pretax Income
    		 -45.45M -41.44M -38.7M -28.29M
    Net Income
    		 -45.43M -41.44M -38.7M -28.29M
    Selling & General & Admin
    		 12.48M 13.04M 13.18M 11.84M
    Research & Development
    		 36.85M 32.86M 27.11M 17.38M
    Other Expenses
    		 n/a n/a n/a -500K
    Operating Expenses
    		 49.33M 45.9M 40.29M 28.71M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 49.33M 45.9M 40.29M 29.21M
    Income Tax Expense
    		 -24K n/a -1.2M -549K
    Shares Outstanding (Basic)
    		 47.65M 44.68M 43.6M 39.03M
    Shares Outstanding (Diluted)
    		 47.65M 44.68M 43.6M 39.03M
    EPS (Basic)
    		 -0.95 -0.93 -0.89 -0.73
    EPS (Diluted)
    		 -0.95 -0.93 -0.89 -0.73
    EBITDA
    		 -48.25M -45.01M -39.67M -28.4M
    EBIT
    		 -48.65M -45.41M -39.9M -28.86M
    Depreciation & Amortization
    		 404K 398K 200K 500K

    Add to Watchlist